Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
NCT ID:
NCT05888766
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of Episodic migraine
* Prescription of Rimegepant 75 mg as abortive treatment for migraine
* headache occurring on \< 15 days/four weeks;
* No other primary/secondary headache disorder;
* No contraindication for Rimegepant 75 mg;
* No previous exposure to any anti-CGRP drugs;
* No prophylactic migraine treatment ongoing or in the past 3 months before participation in the study
Exclusion Criteria:
* headache occurring \>15 days/four weeks
* Contraindication for Rimegepant 75 mg
* Previous exposure to anti-CGRP drugs;
* Prophylactic migraine treatment ongoing or in the past 3 months before participation in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT05888766
Study Brief:
Protocol Section:
NCT05888766